Henry Schein, Inc. company logo

# RNN 1st Gen Model Henry Schein, Inc. Medical & hospital equipment

Prediction models:
78.38% successful of 74 deals
$ 84.39 Last close price
at 17-sep-2018

HSIC

Model's trade recommendations 3.90% Return for period

-14.90% Annual return

$11.82B Market Cap

β 1.04  

HSIC

Model (following trade recommendations)

HSIC

Underlying stock

S&P 500

Index
Return for period 3.90%
3.33%
1.78%
52wk return -51.98%
4.31%
16.82%
52wk Range
63.44—84.53
2000.54—2399.63
Sortino ratio -0.29
Sharpe ratio -0.29
Norm. RMSE 1.36%
Downside risk 30.74%
Volatility 0.00%
  • BUY Analysts consensus recommendation

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics and other alternate care sites. The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of branded products and Henry Schein private-brand products in stock.

Industry sector: Medical

Sector classification: Medical & hospital equipment

Deep Learning based analysis and prediction model for Henry Schein, Inc. (HSIC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for HSIC model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 153M
P/E 21.31
Shares Outstanding 154M
% Held by Insiders 1.15%
% Held by Institutions 96.49%
EPS (last reported FY) $3.60
EPS (last reported Q) $0.97
EPS, estimated (last reported Q) $0.97
Total revenues $12 B
Net income $0 B